Literature DB >> 1572692

Murine splenic null cell compartment contains distinct haemopoietic subpopulations: enlargement of a myeloid and an undifferentiated subset with the development of splenomegaly in New Zealand black mice.

V Manohar1, E M Brown, T M Chused.   

Abstract

We have previously reported that non-T, non-B 'null' cells increase with age in New Zealand Black (NZB) mice resulting in splenomegaly. Using a panel of monoclonal antibodies recognizing lineage-specific cell surface antigens we demonstrate four distinct subsets within this null cell compartment: (1) undifferentiated; (2) T lineage with undetectable Thy-1.2; (3) myeloid/erythroid; and (4) a pre-B/plasma cell type. All four subsets also occur in non-autoimmune mice. The frequency of these populations are similar in the young mice of all the strains examined, although the total number of null cells is higher in NZB. The elevation of null cells in young NZB mice is controlled by a single dominant gene in the genetic cross with New Zealand White (NZW) mice and does not appear closely related to the subsequent development of autoimmune disease. The proportion of myeloid/erythroid null cells increases with age in NZB as splenomegaly develops.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572692      PMCID: PMC1384738     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.

Authors:  G Ortega; R J Robb; E M Shevach; T R Malek
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

2.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

3.  A monoclonal antibody discriminating between subsets of T and B cells.

Authors:  J Bruce; F W Symington; T J McKearn; J Sprent
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

4.  A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.

Authors:  J W Schrader; I Clark-Lewis
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Antigens displayed on murine B lymphocyte precursors.

Authors:  P W Kincade; G Lee; T Watanabe; L Sun; M P Scheid
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

6.  A new xenogenic monoclonal antibody detecting class I H-2 molecules.

Authors:  V Manohar; E M Brown; W M Leiserson; T M Chused
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

7.  Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice.

Authors:  K L McCoy; L Kendrick; T M Chused
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

8.  Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.

Authors:  M K Ho; T A Springer
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

9.  Expression of Lyt-1 by a subset of B lymphocytes.

Authors:  V Manohar; E Brown; W M Leiserson; T M Chused
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  1 in total

1.  Murine splenic hematopoietic subpopulations: the enlarged undifferentiated subset in New Zealand black mice is multipotent stem cells.

Authors:  V Manohar; K Huppi; E Lizzio; T Hoffman
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.